Jump to content
RemedySpot.com

Re: E & T RECEPTORS /dee

Rate this topic


Guest guest

Recommended Posts

Hi Dee,

just by coincidence (maybe?) I developed mild (they are no longer

mild) vulvar problems and now LS within two years of starting HRT. I

was a strange case - partial (left ovaries) hysterectomy over 30

years ago. No systems of menopause at all - on my 63rd birthday I

woke up with raging hot flashes - one every 15 minutes. I couldn't

stand it - my glasses were fogged up - I couldn't see. I went on the

horrible premarin and I am still on it. Now I have every vulvar

problem know to man, and a few that aren't (LOL). Do you see any

connection here with anything?

nne

>

>

>

> HI again... (another long one) *Smile* but this is something I've

sent before about how our 'receptors' work.. and it truly adds to

the understanding of the previous post.

> Dee~

>

> 1.

> Here's one I have on Estrogen and it's ''receptors'':

>

> August 2003 . Volume 189 . Number 2

> Original article

> Lois J. Eva, MRCOG

> Allan B. MacLean, MD, FRCOG

> M.N. Reid, FRCOG

> Kerstin J. Rolfe, MPhil

> W. Perrett, PhD

>

> Estrogen 'receptor' expression in vulvar vestibulitis

syndrome

>

> OBJECTIVE: A pilot study was performed to investigate the

relationship between vulvar vestibulitis syndrome and estrogen

receptor (ER) expression.

>

> STUDY DESIGN: Women with a diagnosis of vulvar vestibulitis

syndrome had tissue samples taken for vulvar estrogen receptor-

expression and this was compared with a control group.

>

> RESULTS: The study group showed a 'significant decrease'' in

estrogen 'receptor' expression, and 50% of the samples did 'not'

exhibit 'any' receptor expression.

>

> CONCLUSION: There appears to be a subgroup of women with

vulvar vestibulitis syndrome who exhibit abnormal estrogen receptor-

expression. This may be helpful in explaining why some women are

resistant to medical treatment and may allow treatment to be

prescribed more effectively. " ... Am J Obstet Gynecol. 2003;189:458-

61. END

> ============================================

>

> Dee here: I don't think I'd call 50% a SUBGROUP, let alone they

showed some with a 'significant' decrease in E. expression and 50%

of those women with V pain had " NO " E receptor expression? DUH! And

estrogen is SO essential not only for our skin but our whole body

including the brain. I myself wonder if many of these women were on

birth control but unfortunately it didn't go into that only that

they had V. pain. But check out the next one. :)

>

> AND...... here's one on the Testosterone Receptors.....

>

> 2.

>

> Androgen Insufficiency May Lead to Vulvar Vestibulitis and

Genital Pain

>

> Yael Waknine

> Oct. 26, 2004 - Androgen insufficiency may result in

diminished structure and function of the vestibular glands,

including decreased androgen receptor expression, leading to

vestibular adenitis and dyspareunia, according to the results of a

preliminary study presented last week at the 11th World Congress of

the International Society for Sexual and Impotence Research in

Buenos Aires, Argentina.

> " Vestibulitis is a very common cause of genital pain among

women, and there's a subgroup of women [in whom] it's probably

related to the use of hormonal 'birth control pills' or hormonal

manipulation, "

>

> *Comment by Dee.... A study I also have from Jan '06 showed

that connection with birth control pills blocking testosterone, (and

Estrogen I might add)

>

> Munarriz, MD, assistant professor of urology at Boston

University School of Medicine in Massachusetts, told Medscape. " That

a small group of women responds to androgen replacement therapy. "

>

> Of 3,000 women with female sexual dysfunction (FSD) evaluated

by Dr. Munarriz and colleagues, 13% had dyspareunia, 66% had

physical findings of vulvar vestibulitis syndrome (VVS), and 83% had

concomitant androgen deficiency.

>

> To evaluate the possibility of a link between 'androgen

deficiency' and vestibulitis, the investigators compared vestibular

gland tissue excised from patients with VVS (n = 22; mean age, 36

years; 32 sections) with vestibular tissues excised from female

cadavers having had no history of vestibulitis (control subjects, n

= 5; 9 sections).

>

> Patients with VVS had significant dyspareunia as evaluated

using the pain domain of the Female Sexual Function Index (mean

score, 0.9 ± 0.06; maximal score = 5).

>

> Hematoxylin-eosin staining showed significant inflammation (P

= .00009) and squamous metaplasia in the vestibular specimens of

patients with VVS compared with control subjects.

>

> Immunohistochemical staining with antibody anti-estrogen,

progesterone, and anti-androgen showed significant decreases in

androgen (P = .014) and progesterone (P = .00042) ''receptor''

expression in vestibular tissue of patients with VVS compared with

controls.

>

> " What we found is that the specimens from women who had

vestibulitis had 'significant' inflammation, squamous metaplasia,

and were completely 'depleted' of androgen 'receptors' - while the

controls had no inflammation, and normal staining for androgens, "

noted Dr. Munarriz.

>

> " This makes us believe that there is a link between genital

pain due to vestibulitis and androgens.

>

> " We believe that there's a subgroup of women, particularly

young women, who as a consequence of being on the birth control pill

have very low androgen or testosterone levels, " said Dr. Munarriz,

noting that these women also tend to have a higher incidence of

genital pain. " This may be one of the pathophysiologic mechanisms

[explaining] why women on the pill get pain - because they lose

their ability to express androgen receptors in the genital tissue, "

he said.

>

> " On the basis of this premise, it may be that in this subgroup

of women genital pain can be effectively treated with hormones, "

concluded Dr. Munarriz, adding that future studies may evaluate the

benefits of testosterone therapy in this population.

>

> The investigators report no pertinent financial conflicts of

interest.ISSIR 11th World Congress: Abstract O74. Presented Oct. 20,

2004. Reviewed by D. Vogin, MD

>

> ====================================

>

> One last one and again I apologize for the length, but you'll

see how Birth Control methods also can block those 'receptors' (by

creating more SHBG which binds/blocks our receptors & explained

below) By the way the shot Depo-Provera is absolutely one of the

worst in my opinion and is 100% a progestin. *sigh*

>

> Dee

>

> 3.

>

> BIRTH CONTROL AND TESTOSTERONE PROBLEMS.

>

> New research indicates birth control pill could cause long-

term problems with testosterone

> In the January '06 issue of The Journal of Sexual Medicine,

researchers have published a new investigation measuring sex hormone

binding globulin (SHBG) before and after discontinuation of the oral

contraceptive pill.

>

> The research concluded that women who used the oral

contraceptive pill may be exposed to long-term problems from low

values of " unbound " testosterone potentially leading to continuing

sexual, metabolic, and mental health consequences.

>

> Sex hormone binding globulin (SHBG) is the protein that

binds testosterone, rendering it 'unavailable' for a woman's

physiologic needs.

>

> (Comment by Dee: That means the higher the SHBG the lower

the Testosterone (and the estrogen) it's bound up and

unavailable)

>

> The study showed that in women with sexual dysfunction,

elevated SHBG in " Oral Contraceptive Discontinued-Users " did not

decrease to values consistent with those of " Never-Users of Oral

Contraceptive " .

>

> Thus, as a consequence of the chronic elevation in sex

hormone binding globulin levels, pill users may be at risk for long-

standing health problems, including sexual dysfunction.

>

> Oral contraceptives have been the preferred method of birth

control because of their ease of use and high rate of effectiveness.

However, in some women oral contraceptives have ironically been

associated with women's sexual health problems and testosterone

hormonal problems.

>

> Now there are data that oral contraceptive pills may

have ''lasting'' adverse effects on the hormone testosterone.

>

> The research, in an article entitled: " Impact of Oral

Contraceptives on Sex Hormone Binding Globulin and Androgen Levels:

A Retrospective Study in Women with Sexual Dysfunction " published in

The Journal of Sexual Medicine, involved 124 premenopausal women

with sexual health complaints for more than 6 months.

>

> Three groups of women were defined: i) 62 " Oral

Contraceptive Continued-Users " had been on oral contraceptives for

more than 6 months and continued taking them, ii) 39 " Oral

Contraceptive Discontinued-Users " had been on oral contraceptives

for more than 6 months and discontinued them, and iii) 23 " Never-

Users of Oral Contraceptives " had never taken oral contraceptives.

>

> SHBG values were compared at baseline (groups i, ii and

iii), while on the oral contraceptive (groups i and ii), and well

beyond the 7 day half-life of sex hormone binding globulin at 49-120

(mean 80) days and more than 120 (mean 196) days after

discontinuation of oral contraceptives (group ii).

>

> The researchers concluded that SHBG values in the " Oral

Contraceptive Continued-Users " were 4 times higher than those in

the " Never-Users of Oral Contraceptives " .

>

> Despite a decrease in SHBG values after discontinuation of

oral contraceptive pill use, SHBG levels in " Oral Contraceptive

Discontinued-Users " remained elevated when compared to " Never-Users

of Oral Contraceptives " .

>

> This led to the question of whether prolonged exposure to

the synthetic estrogens of oral contraceptives induces gene

imprinting and increased gene expression of SHBG in the liver in

some women who have used the oral contraceptives.

>

> Dr. Panzer, an endocrinologist in Denver, CO and

lead author of the study, noted that " it is important for physicians

prescribing oral contraceptives to point out to their patients

potential sexual side effects, such as decreased desire (loss of

libido) , arousal, decreased lubrication and increased sexual pain.

>

> Also if women present with these complaints, it is crucial

to recognize the link between sexual dysfunction and the oral

contraceptive and not to attribute these complaints solely to

psychological causes. "

>

> " An interesting observation was that the use of oral

contraceptives led to changes in the synthesis of SHBG which were

not completely reversible in our time frame of observation.

>

> This can lead to lower levels of 'unbound' testosterone,

(note* the unbound portion is the active and beneficial/working

portion and it may 'not' be reversible. Dee T) which is thought to

play a major role in female sexual health.

>

> It would be important to conduct long-term studies to see if

these increased SHBG changes are permanent, " added Dr. Panzer.

>

> (NOTE* another recent study was done & showed those

negative effects may last as long as several years or more! Dee)

>

> Dr. Andre Guay, study co-author and Director of the Center

for Sexual Function/Endocrinology in Peabody, MA affirmed that this

study is a revelation and that the results have been remarkable.

>

> " For years we have known that a subset of women using oral

contraceptive agents suffer from decreased sex drive, " states Dr.

Guay.

>

> " We know that the birth control pill suppresses both

ovulation and also the male hormones that the ovaries make in larger

amounts during the middle third of the menstrual cycle. SHBG 'binds'

up the testosterone, therefore, these pills 'decrease' a woman's

male hormone availability by two separate mechanisms. No wonder so

many women have had symptoms. "

>

> " This work is the culmination of 7 years of observational

research in which we noted in our practice many women with sexual

dysfunction who had used the oral contraceptive but whose sexual and

hormonal problems persisted despite stopping the birth control

pill, " said Dr. Irwin Goldstein, a urologist and senior author of

the research.

>

> " There are approximately 100 million women worldwide who

currently use oral contraceptives, so it is obvious that more

extensive research investigations are needed.

>

> The oral contraceptive has been around for over 40 years,

but no one had previously looked at the long-term effects of SHBG in

these women. The larger problem is that there have been limited

research efforts in women's sexual health problems in contrast to

investigatory efforts in other areas of women's health or even in

male sexual dysfunction. "

>

> To better appreciate the scope of the problem, oral

contraceptives were introduced in the USA in 1960 and are currently

used for reversible pharmacologic birth control by over 10 million

women in the US, including 80% of all American women born since 1945

and, more specifically, 27% of women ages 15-44 and 53% of women age

20-24 years.

>

> By providing a potent 'synthetic' estrogen (ethinyl

estradiol) and a potent synthetic progesterone (for example -

norethindrone), highly effective contraception is achieved by

diminishing the levels of FSH and LH, thereby reducing metabolic

activity of the ovary including the suppression of ovulation.

>

> Several studies over the last 30 years reported negative

effects of oral contraceptives on sexual function, including

diminished sexual interest and arousal, suppression of female

initiated sexual activity, decreased frequency of sexual intercourse

and sexual enjoyment.

>

> Androgens such as testosterone are important modulators of

sexual function. Oral contraceptives decrease the circulating levels

of androgens by direct inhibition of androgen production in the

ovaries and by a marked increase in the hepatic synthesis of sex-

hormone binding globulin, the major binding protein for gonadal

steroids in the circulation.

>

> The combination of these two mechanisms leads to 'low'

circulating levels of " unbound " or " free " testosterone.

>

> (and it's the unbound & free portion we need and want that

is the working part. Dee)

>

>

>

> Thanks for reading it to the end..*grin* whoever made it, you

must be a saint, but I do hope it helps a bit to explain why

adding 'topical' natural bio-identical hormones like the E & T and

used topically is rarely systemic and why most ages can use it, can

be so beneficial for that V. tissue for many of us.

>

> Not everyone of course, and that's 'my' opinion as I realize

there are other various causes but if that tissue needs rebuilt,

to 'me' there is nothing is better that can do that if our own body

does not respond to bring us back, than the E & T if the problem is

with the skin itself. Also to say that if a woman is on HRT

replacement... that it's minimal help directly for the genitals and

many physicians feel there must be a direct local application (and I

agree) as the systemic generally doesn't help or at best it's

minimal.

>

> I can only say it definitely was 'my' answer after suffering

thru 10 years of hell and trying so many other things that for 'me'

just didn't do a thing and it just 'might' be the answer for someone

else out there. I hope so.

>

> Hugs to all,

>

> Dee~ ;)

>

Link to comment
Share on other sites

Join the conversation

You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.

Guest
Reply to this topic...

×   Pasted as rich text.   Paste as plain text instead

  Only 75 emoji are allowed.

×   Your link has been automatically embedded.   Display as a link instead

×   Your previous content has been restored.   Clear editor

×   You cannot paste images directly. Upload or insert images from URL.

Loading...
×
×
  • Create New...